Literature DB >> 24298977

Impact of fetal development on neurocognitive performance of adolescents with cyanotic and acyanotic congenital heart disease.

Samantha M Matos1, Sofia Sarmento, Sara Moreira, Maria Manuela Pereira, Jorge Quintas, Bruno Peixoto, José Carlos Areias, Maria Emília G Areias.   

Abstract

BACKGROUND: Our aims were to evaluate the neurocognitive performance in adolescents with congenital heart disease (CHD) and to determine whether parameters of fetal development evaluated in neonates, such as head circumference, length, weight, and Apgar scores, are somehow related to their neurocognitive performance.
METHODS: We evaluated 77 CHD patients (43 males) aged from 13 to 18 years old (mean = 15.04 ± 1.86), 46 cyanotic, 23 with tetralogy of Fallot (TF), 23 with transposition of the great arteries (TGA) and 31 acyanotic with ventricular septal defect (VSD) enrolled in this study. The control group included 16 healthy children (11 males) ages ranging from 13 to 18 years old (mean = 15.69 years ± 1.44 years). All assessment measures for CHD patients were once obtained in a tertiary hospital; the control group was evaluated in school. Neuropsychological assessment included Wechsler's Digit Test, direct and reverse (WDD and WDR) and Symbol Search, Rey's Complex Figure (RCF), BADS's Key Searching Test, Color-Word Stroop Test (CWS), Trail Making Test (TMT), and Logical Memory Task (LMT). We evaluated some fetal parameters, such as head circumference, weight and length assessed at birth, and neonatal parameters, such as Apgar scores at 1 and 5 minutes after birth. We also registered some surgical parameters, such as the age at first operation and the number of surgeries.
RESULTS: CHD patients compared with control group showed lower scores on every test, except for logical memory task. Patients with VSD when compared with patients with TF and TGA showed better results in all neuropsychological tests, although the only significant differences were in RCF, copy (F = 4936; P = .010). Several correlations were apparent between fetal/neonatal parameters and neuropsychological abilities in each type of CHD. However, head circumference at birth stands as the main correlation with cognitive development later on in all kinds of CHD (WDD: rho = .339, P = .011; RCF, copy: rho = 0.297, P = .027; CWS, interference: rho = 0.283, P = .036; TMT-A: rho = -0.321, P = .017). We analyzed the predicting relevance of several variables to cognitive performance of adolescents with CHD and confirmed that "cyanosis" stands as the main predictor (â = -4.758; t = -2.622; P = .011).
CONCLUSIONS: Adolescents with CHD have worse neuropsychological performance than the control group, mainly the cyanotic patients. Fetal circulation seems to have impact on cerebral and somatic growth, predicting cognitive impairment in adolescents with CHD.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Congenital Heart Disease; Fetal Development; Neonatal Variables; Neurocognitive Functioning

Mesh:

Year:  2013        PMID: 24298977     DOI: 10.1111/chd.12152

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  7 in total

1.  Fetal Growth and Neurodevelopmental Outcome in Congenital Heart Disease.

Authors:  Ismée A Williams; William P Fifer; Howard Andrews
Journal:  Pediatr Cardiol       Date:  2015-03-10       Impact factor: 1.655

2.  In Utero Evidence of Impaired Somatic Growth in Hypoplastic Left Heart Syndrome.

Authors:  Jourdan E Triebwasser; Marjorie C Treadwell
Journal:  Pediatr Cardiol       Date:  2017-07-08       Impact factor: 1.655

Review 3.  Neuropsychological and Psychiatric Outcomes in Dextro-Transposition of the Great Arteries across the Lifespan: A State-of-the-Art Review.

Authors:  Leila Kasmi; Damien Bonnet; Michèle Montreuil; David Kalfa; Nikoletta Geronikola; David C Bellinger; Johanna Calderon
Journal:  Front Pediatr       Date:  2017-03-24       Impact factor: 3.418

Review 4.  'Big issues' in neurodevelopment for children and adults with congenital heart disease.

Authors:  Charlotte E Verrall; Gillian M Blue; Alison Loughran-Fowlds; Nadine Kasparian; Jozef Gecz; Karen Walker; Sally L Dunwoodie; Rachael Cordina; Gary Sholler; Nadia Badawi; David Winlaw
Journal:  Open Heart       Date:  2019-07-03

Review 5.  MRI studies of brain size and growth in individuals with congenital heart disease.

Authors:  Alexandra F Bonthrone; Christopher J Kelly; Isabel H X Ng; Serena J Counsell
Journal:  Transl Pediatr       Date:  2021-08

6.  Health comorbidities and cognitive abilities across the lifespan in Down syndrome.

Authors:  Carla M Startin; Hana D'Souza; George Ball; Sarah Hamburg; Rosalyn Hithersay; Kate M O Hughes; Esha Massand; Annette Karmiloff-Smith; Michael S C Thomas; Andre Strydom
Journal:  J Neurodev Disord       Date:  2020-01-23       Impact factor: 4.025

7.  Adults With Mild-to-Moderate Congenital Heart Disease Demonstrate Measurable Neurocognitive Deficits.

Authors:  Melissa L Perrotta; Priyanka Saha; Roy Zawadzki; Mark Beidelman; Erik Ingelsson; George K Lui; James R Priest
Journal:  J Am Heart Assoc       Date:  2020-09-28       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.